Talus Bio
Discovering drugs that target the DNA regulome
We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.
- Website
- talus.bio
- City
- Seattle
- Country
- United States
- YC batch
- Summer 2021
- Team
- 16 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in Seattle
Institute for Protein DesignLab
University of Washington centre for computational protein design.
Rebellyous Foods
Rebellyous Foods is a food manufacturing technology and production…
adynHiring
The first test designed to prevent birth control side effects
BloomAPI
BloomAPI helps doctors share clinical data. Today most healthcare…
HubbleHiring
AI-native retrieval engine for medical records
Sigma Genetics
Sigma Genetics is a biotechnology company that is building…
Claim this profile
Free and instant: prove you run talus.bio and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Talus Bio across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Talus Bio's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
